BUY Divi's Laboratories Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))18 Jun 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·14 May · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- BUY — Ashish Bahety, Profitmart Securities22 Oct 2026 · Same day · target ₹9,350 · SL hit
- SELL — Prakash Gaba14 Oct 2026 · ~2 weeks · target ₹8,750 · SL hit
- SELL — Mehul Kothari, Anand Rathi14 Oct 2026 · ~2 weeks · target ₹8,400 · Active
- BUY — Kavita Jain, Arihant Capital Markets6 Oct 2026 · Next day · target ₹9,750 · Expired
- BUY — Chandan Taparia, Motilal Oswal24 Sept 2026 · ~2 weeks · target ₹10,000 · SL hit
More from Manas Jaiswal
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY Coforge22 Oct 2026 · Same day · target ₹2,010 · SL hit
- BUY Tata Consultancy Services22 Oct 2026 · ~2 weeks · target ₹2,625 · Active
- SELL SRF21 Oct 2026 · ~2 weeks · target ₹1,975 · Active
- SELL Trent21 Oct 2026 · ~2 weeks · target ₹2,700 · Active

